132 related articles for article (PubMed ID: 37750364)
21. Early onset pancreatic cancer: a controlled trial.
Tingstedt B; Weitkämper C; Andersson R
Ann Gastroenterol; 2011; 24(3):206-212. PubMed ID: 24713777
[TBL] [Abstract][Full Text] [Related]
22. The Global Burden of Early-Onset Pancreatic Cancer and Its Risk Factors: A Perspective From Global Burden of Disease Study 2019.
Danpanichkul P; Suparan K; Jaroenlapnopparat A; Polpichai N; Fangsaard P; Detboon A; Moolkaew P; Sripusanapan A; Srisurapanont K; Kanjanakot Y; Duangsonk K; Wallace MB; Wijarnpreecha K
Pancreas; 2024 May; 53(5):e434-e444. PubMed ID: 38530945
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide association study identifies an early onset pancreatic cancer risk locus.
Campa D; Gentiluomo M; Obazee O; Ballerini A; Vodickova L; Hegyi P; Soucek P; Brenner H; Milanetto AC; Landi S; Gao X; Bozzato D; Capurso G; Tavano F; Vashist Y; Hackert T; Bambi F; Bursi S; Oliverius M; Gioffreda D; Schöttker B; Ivanauskas A; Mohelnikova-Duchonova B; Darvasi E; Pezzilli R; Małecka-Panas E; Strobel O; Gazouli M; Katzke V; Szentesi A; Cavestro GM; Farkas G; Izbicki JR; Moz S; Archibugi L; Hlavac V; Vincze Á; Talar-Wojnarowska R; Rusev B; Kupcinskas J; Greenhalf B; Dijk F; Giese N; Boggi U; Andriulli A; Busch OR; Vanella G; Vodicka P; Nentwich M; Lawlor RT; Theodoropoulos GE; Jamroziak K; Zuppardo RA; Moletta L; Ginocchi L; Kaaks R; Neoptolemos JP; Lucchesi M; Canzian F
Int J Cancer; 2020 Oct; 147(8):2065-2074. PubMed ID: 32270874
[TBL] [Abstract][Full Text] [Related]
24. Is colorectal cancer a more aggressive disease in young patients? A population-based study from the Czech Republic.
Kocián P; Svobodová I; Krejčí D; Blaha M; Gürlich R; Dušek L; Hoch J; Whitley A
Cancer Epidemiol; 2019 Dec; 63():101621. PubMed ID: 31634775
[TBL] [Abstract][Full Text] [Related]
25. Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis.
Blackford AL; Canto MI; Klein AP; Hruban RH; Goggins M
J Natl Cancer Inst; 2020 Nov; 112(11):1162-1169. PubMed ID: 31958122
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic cancer; reporting and long-term survival in Sweden.
Lambe M; Eloranta S; Wigertz A; Blomqvist P
Acta Oncol; 2011 Nov; 50(8):1220-7. PubMed ID: 21812626
[TBL] [Abstract][Full Text] [Related]
27. Genetic and non-genetic risk factors for early-onset pancreatic cancer.
Nodari Y; Gentiluomo M; Mohelnikova-Duchonova B; Kreivenaite E; Milanetto AC; Skieceviciene J; Landi S; Lawlor RT; Petrone MC; Arcidiacono PG; Lovecek M; Gazouli M; Bijlsma MF; Morelli L; Kiudelis V; Tacelli M; Zanette DL; Soucek P; Uzunoglu F; Kaaks R; Izbicki J; Boggi U; Pezzilli R; Mambrini A; Pasquali C; van Laarhoven HW; Katzke V; Cavestro GM; Sperti C; Loos M; Latiano A; Erőss B; Oliverius M; Johnson T; Basso D; Neoptolemos JP; Aoki MN; Greenhalf W; Vodicka P; Archibugi L; Vanella G; Lucchesi M; Talar-Wojnarowska R; Jamroziak K; Saeedi MA; van Eijck CHJ; Kupcinskas J; Hussein T; Puzzono M; Bunduc S; Götz M; Carrara S; Szentesi A; Tavano F; Moz S; Hegyi P; Luchini C; Capurso G; Perri F; Ermini S; Theodoropoulos G; Capretti G; Palmieri O; Ginocchi L; Furbetta N; Canzian F; Campa D
Dig Liver Dis; 2023 Oct; 55(10):1417-1425. PubMed ID: 36973108
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of 10-Year Survivors of Pancreatic Ductal Adenocarcinoma.
Paniccia A; Hosokawa P; Henderson W; Schulick RD; Edil BH; McCarter MD; Gajdos C
JAMA Surg; 2015 Aug; 150(8):701-10. PubMed ID: 26062046
[TBL] [Abstract][Full Text] [Related]
29. Treatment patterns and survival outcomes in patients with non-metastatic early-onset pancreatic cancer.
Zhang LT; Zhang Y; Cao BY; Wu CC; Wang J
World J Gastroenterol; 2024 Mar; 30(12):1739-1750. PubMed ID: 38617739
[TBL] [Abstract][Full Text] [Related]
30. Predictors of Survival among Early Onset Pancreatic Adenocarcinoma Patients A Tertiary Care Center Experience.
Alkashash AM; Elsebaie MA; Bikhet MH; Morsi M; Paluri RK
Chirurgia (Bucur); 2021; 116(1):24-33. PubMed ID: 33638323
[TBL] [Abstract][Full Text] [Related]
31. Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis.
McWilliams RR; Maisonneuve P; Bamlet WR; Petersen GM; Li D; Risch HA; Yu H; Fontham ET; Luckett B; Bosetti C; Negri E; La Vecchia C; Talamini R; Bueno de Mesquita HB; Bracci P; Gallinger S; Neale RE; Lowenfels AB
Pancreas; 2016 Feb; 45(2):311-6. PubMed ID: 26646264
[TBL] [Abstract][Full Text] [Related]
32. Trends in the Incidence and Treatment of Early-Onset Pancreatic Cancer.
LaPelusa M; Shen C; Arhin ND; Cardin D; Tan M; Idrees K; Geevarghese S; Chakravarthy B; Berlin J; Eng C
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053447
[TBL] [Abstract][Full Text] [Related]
33. Association of Glycated Hemoglobin Levels With Risk of Pancreatic Cancer.
Wu BU; Butler RK; Lustigova E; Lawrence JM; Chen W
JAMA Netw Open; 2020 Jun; 3(6):e204945. PubMed ID: 32530471
[TBL] [Abstract][Full Text] [Related]
34. Trends in incidence of childhood cancers in the Czech Republic: population- based analysis of national registries (1994-2014).
Kodytkova D; Bajciova V; Krejci D; Zapletalova M; Dusek V; Jarkovsky J; Muzik J; Klimes D; Stary J; Smelhaus V; Vrzalova A; Janotova I; Sterba J; Dusek L
Neoplasma; 2018; 65(4):620-629. PubMed ID: 30064234
[TBL] [Abstract][Full Text] [Related]
35. Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy.
Ishida J; Toyama H; Matsumoto I; Asari S; Goto T; Terai S; Nanno Y; Yamashita A; Mizumoto T; Ueda Y; Kido M; Ajiki T; Fukumoto T; Ku Y
Pancreatology; 2016; 16(4):615-20. PubMed ID: 27237099
[TBL] [Abstract][Full Text] [Related]
36. Body mass index and pancreatic adenocarcinoma: A nationwide registry-based cohort study.
Saeed U; Myklebust TÅ; Robsahm TE; Møller B; Mala T; Skålhegg BS; Yaqub S
Scand J Surg; 2023 Mar; 112(1):11-21. PubMed ID: 36173093
[TBL] [Abstract][Full Text] [Related]
37. Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma.
Cloyd JM; Wang H; Egger ME; Tzeng CD; Prakash LR; Maitra A; Varadhachary GR; Shroff R; Javle M; Fogelman D; Wolff RA; Overman MJ; Koay EJ; Das P; Herman JM; Kim MP; Vauthey JN; Aloia TA; Fleming JB; Lee JE; Katz MHG
JAMA Surg; 2017 Nov; 152(11):1048-1056. PubMed ID: 28700784
[TBL] [Abstract][Full Text] [Related]
38. Temporal trends of pancreatic ductal adenocarcinoma in young adults in the United States: A Population-Based Study.
Gad MM; Saad AM; Al-Husseini MJ; Abdel-Gawad YM; Alsalhani OM; Alhaddad R; Mohamad B; Saleh MA; Simons-Linares CR
Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):204-210. PubMed ID: 31420297
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics of long-term survivors of inoperable pancreatic cancer: an 8-year cohort analysis in Korea.
Jo JH; Chung MJ; Park JY; Bang S; Park SW; Chung JB; Song SY
Pancreas; 2014 Oct; 43(7):1022-31. PubMed ID: 24991970
[TBL] [Abstract][Full Text] [Related]
40. Defining the optimal timing of adjuvant therapy for resected pancreatic adenocarcinoma: A statewide cancer registry analysis.
Saeed H; Hnoosh D; Huang B; Durbin EB; McGrath PC; Desimone P; Maynard E; Anthony LB; Dineen SP; Hosein PJ; Tzeng CW
J Surg Oncol; 2016 Sep; 114(4):451-5. PubMed ID: 27238300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
